New and Noteworthy

Showing 9 of 0 results

• A scoping review of real-world data sources for retrospective oncology analysis in Japan

  ESMO Real World Data and Digital Oncology

  • Publication summary
  • Publications
• A conversation with Dr. Ronac Mamtani on the evidence that moves oncology forward
  • Real-world evidence
  • Event recap
• ASCO 2026: Translating oncology innovation into real-world impact
  • Real-world evidence
  • Event recap
  • Article
• Rewriting the real-world evidence playbook for clinical development
  • Real-world evidence
  • Artificial intelligence
  • Data management
• ISPOR 2026 reflections: AI, access, and the evolving role of RWE in oncology
  • Real-world evidence
  • Event recap
  • HTA and market access
  • Artificial intelligence
• From plenary to practice: A large language model (LLM)-based thematic analysis of landmark clinical trial discussions and factors influencing their real-world adoption

  ASCO Annual Meeting

  • Publication summary
  • Publications
  • Machine learning
  • Artificial intelligence
• Real-world biomarker testing rates, targeted therapy use, and clinical outcomes in patients with advanced gastric or GEJ cancer in the United States

  ASCO Annual Meeting

  • Publication summary
  • Publications
  • Precision medicine
  • Gastric/Esophageal cancer
• Drivers of organotropism and patterns of metastatic progression in metastatic non-small cell lung cancer

  ASCO Annual Meeting

  • Publication summary
  • Publications
  • Non-small cell lung cancer
• Comparison of real-world overall survival between atezolizumab- and durvalumab-containing first- line induction and maintenance regimens in extensive-stage small cell lung cancer

  ASCO Annual Meeting

  • Publication summary
  • Publications
  • Comparative effectiveness
  • Small cell lung cancer